Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

23rd Annual Diabetes Fall Symposium for Primary Health Care Professionals


- 23rd Annual -
Diabetes Fall Symposium for Primary Health Care Professionals
October 12, 2019
MUSC Drug Discovery Auditorium, 97 Jonathan Lucas Street, Charleston, SC
 
To register online, Web address coming soon!
To view the final brochure (and to register via mail), click here!
To visit the Diabetes Initiative of SC website, click here!
 
This comprehensive update is specifically designed for Primary Care Physicians, Podiatrists, Endocrinologists, Pharmacists, PharmDs, NPs, APRNs, PAs, RDs, and CDEs. The information to be presented is equally relevant to RNs, LPNs, and Social Workers.
 
Program Learning Objectives
At the conclusion of the program, participants should be able to:
  • Identify outcomes from the DCCT (Diabetes Control and Complications Trial)/EDIC (Epidemiology of Diabetes Interventions and Complications) studies from 1983 to the present,
  • Discuss the relationship of health diaparities to pregnancy outcomes,
  • List two ways Telemedicine/Telehealth is changing healthcare,
  • Analyze strategies to manage and prevent obesity in patients with diabetes in South Carolina,
  • Describe the correlation of pre-eclampsia with diabetes,
  • Define the connection of gum disease and diabetes,
  • Assess the prevalence of testosterone deficiency with diabetes,
  • Explain the management of diabetes with Diabetic Liver Disease (DLD),
  • Compare novel pharmacotherapies for the treatment of diabetes.
To view the schedule of individual sessions as well as their learning objectives, please scroll to the bottom of the page. 
Clicking on the blue bars will expand the session details!

Date: Oct 12, 2019 08:00 AM - 04:30 PM

CE Hours

7.00

CE Units

0.700

Activity Type

  • Knowledge-Based and Application-Based

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Diabetes Initiative of SC

Requirements for CE Credit

Participants must sign in upon arrival and have attendance verified. To claim credit for this activity, participants must complete the online program evaluation and must update their accounts to properly reflect their month/day of birth and correct NABP e-Profile ID.  To register with NABP or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site. Credit that is claimed greater than 60 days from the date of the program will be automatically rejected by the CPE Monitor.  Claiming credit within 30 days of the live program will ensure that any issues with transmission to the CPE Monitor can be rectified in advance of the 60-day deadline.  If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-Profile.

 

 

 

   

At the completion of this activity, the participant will be able to:
  1. Identify outcomes from the DCCT/EDIC studies from 1983 to the present
  2. Describe metabolic consequences of intensive insulin treatment
  3. Discuss challenges for the future

Speaker(s)/Author(s)

Timothy J. Lyons, MD, FACE
Professor of Medicine; Director, Division of Endocrinology, MUSC

Activity Number

0062-9999-19-141-L01-P
Date: 10/12/19
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
   

   

At the completion of this activity, the participant will be able to:
  1. Discuss the relationship of health disparities to pregnancy outcomes
  2. Identify racial/ethnic high-risk groups
  3. Describe opportunities related to obstetrical care

Speaker(s)/Author(s)

Aundrea Loftley, MD
Assistant Professor of Medicine; Division of Endocrinology, Diabetes and Metabolic Diseases, MUSC

Activity Number

0062-9999-19-142-L01-P
Date: 10/12/19
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
   

   

At the completion of this activity, the participant will be able to:
  1. List two ways Telemedicine/Telehealth is changing healthcare
  2. Define Telemedicine/Telehealth
  3. Describe who can provide services

Speaker(s)/Author(s)

James T. McElligott, MD, MSCR
Assistant Professor of Medicine; Medical Director, Center for Telehealth, MUSC

Activity Number

0062-9999-19-143-L01-P
Date: 10/12/19
Time: 10:30 AM - 11:30 AM

CE Hours

1.00
   

   

At the completion of this activity, the participant will be able to:
  1. Analyze strategies to manage or prevent obesity in patients with diabetes in South Carolina
  2. Define overweight and obesity
  3. Discuss statistics for adults and children

Speaker(s)/Author(s)

Harsha Karanchi, MD
Assistant Professor of Medicine, Division of Endocrinology, Diabetes and Metabolic Diseases, Medical University of South Carolina

Activity Number

0062-9999-19-144-L01-P
Date: 10/12/19
Time: 11:30 AM - 12:30 PM

CE Hours

1.00
   

   

At the completion of this activity, the participant will be able to:
  1. Describe the correlation of pre-eclampsia with diabetes
  2. Discuss diagnostic criteria for pre-eclampsia.
  3. Identify pre-eclampsia in women with Type 2 and gestational diabetes

Speaker(s)/Author(s)

Clare Kelly, PhD
Junior Scientist; Division of Endocrinology, Diabetes & Medical Genetics, MUSC

Activity Number

0062-9999-19-145-L01-P
Date: 10/12/19
Time: 01:15 PM - 01:45 PM

CE Hours

0.50
   

   

At the completion of this activity, the participant will be able to:
  1. Define the connection of gum disease with diabetes
  2. List two common mouth problems
  3. Describe prevention strategies

Speaker(s)/Author(s)

Renata Leite, MD, DDS
Assistant Professor of Medicine; College of Dental Medicine, Department of Stomatology, MUSC

Activity Number

0062-9999-19-146-L01-P
Date: 10/12/19
Time: 01:45 PM - 02:15 PM

CE Hours

0.50
   

   

At the completion of this activity, the participant will be able to:
  1. Identify the prevalence of testosterone deficiency with diabetes
  2. Describe the relationship of testosterone deficiency to metabolic syndrome, dyslipidemia and hypertension
  3. Discuss screening and diagnosing criteria

Speaker(s)/Author(s)

Jyotika Fernandes, MD
Professor of Medicine; Division of Endocrinology, Diabetes and Metabolic Diseases, MUSC

Activity Number

0062-9999-19-147-L01-P
Date: 10/12/19
Time: 02:15 PM - 02:45 PM

CE Hours

0.50
   

   

At the completion of this activity, the participant will be able to:
  1. Explain the management of diabetes with Diabetic Liver Disease (DLD)
  2. Discuss the prevalence of Diabetic Liver Disease (DLD)
  3. Recognize parameters for monitoring glycemic control

Speaker(s)/Author(s)

Wing-Kin Syn, PhD, MBBS
Associate Professor of Medicine; Division of Gastroenterology and Hepatology, MUSC

Activity Number

0062-9999-19-148-L01-P
Date: 10/12/19
Time: 02:45 PM - 03:15 PM

CE Hours

0.50
   

   

At the completion of this activity, the participant will be able to:
  1. Compare novel pharmacotherapies for the treatment of diabetes
  2. Discuss efficacy of GLP1-RAs
  3. Describe additional considerations for GLP1-RAs and SGLT-2 inhibitors

Speaker(s)/Author(s)

Betul Hatipoglu, MD
Clinical Associate Professor of Medicine; Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic

Activity Number

0062-9999-19-149-L01-P
Date: 10/12/19
Time: 03:30 PM - 04:30 PM

CE Hours

1.00